SCHEMBL5686147

SCHEMBL5686147

NC(=O)c1c(Oc2ccccc2OCc2ccccc2)nc(N)nc1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGMT P16455 2/20 0.45
CDK1 P06493 1/20 0.45
CCNB1 P14635 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
CCNA1 P78396 1/20 0.45
DCPS Q96C86 1/20 0.42
HTT P42858 1/20 0.42
RXRA P19793 1/20 0.41
DHFR P00374 1/20 0.41
ATM Q13315 1/20 0.41
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
MAPT P10636 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LTA4H P09960 1/20 0.39
MAPK14 Q16539 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5689008 0.86 LMNA (0.43) HTTDHFRADORA2AADORA1MAPT
SCHEMBL5686125 0.86 PARP10 (0.50) MGMTCDK1CCNB1CCNA2CDK2
SCHEMBL4559145 0.79 ADORA2A (0.56) ADORA2AADORA1
SCHEMBL5686383 0.78 BTK (0.41) ADORA2AADORA1KDM4EALDH1A1
SCHEMBL4559639 0.75 ADORA2A (0.39) ADORA2AADORA1KDM4EALDH1A1
SCHEMBL4559176 0.74 SIRT2 (0.45) ADORA2AADORA1MAPTNPSR1KDM4E
SCHEMBL4559977 0.72 TSHR (0.47) HTTADORA2AADORA1MAPTNPSR1
SCHEMBL5743109 0.71 FOLH1 (0.57) HTTRXRAATMMAPTMRGPRX4
SCHEMBL15621967 0.71 DHFR (0.52) DHFRADORA2AADORA1MAPTNPSR1
SCHEMBL27803763 0.71 KMT2A (0.42) MGMTCDK1CCNB1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648464-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINCARBOXAMID DERIVATIVES AND RELATED COMPOUNDS AS T-CELL ACTIVATION INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2006-04-26 EP disclosed
WO-2005009443-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF T CELL ACTIVATION FOR THE TREATMENT OF INFLAMMATORY DISEASES AMGEN INC. (US) 2005-02-03 WO disclosed